Clovis Oncology Shares Down 64.9% Since SmarTrend's Sell Call (CLVS)

SmarTrend identified a Downtrend for Clovis Oncology (NASDAQ:CLVS) on July 25th, 2018 at $44.69. In approximately 4 months, Clovis Oncology has returned 64.89% as of today's recent price of...